Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 5/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8969657 | 0.88 | TSHR (0.46) | APPMAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL670276 | 0.86 | MAPK1 (0.46) | APPMAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL29584039 | 0.86 | MAPK1 (0.46) | APPMAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL3657469 | 0.84 | APP (0.46) | APPMAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL30500239 | 0.84 | APP (0.46) | APPMAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL13645864 | 0.81 | DRD2 (0.50) | MAPK1CYP1A2CYP2D6CYP2C19KDM4E | |
| SCHEMBL23907052 | 0.81 | TP53 (0.43) | APPMAPK1L3MBTL1 | |
| SCHEMBL10048853 | 0.81 | CYP1A2 (0.53) | APPMAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL13846053 | 0.81 | CYP1A2 (0.53) | APPMAPK1CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL4185408 | 0.80 | APP (0.47) | APPCTNNB1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7005440-B1 | Therapeutic uses of tri-aryl acid derivatives | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2006-02-28 | — | — | US | disclosed |
| EP-1177176-A1 | TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS | Aventis Pharma Deutschland GmbH (DE) | 2002-02-06 | — | — | EP | disclosed |
| WO-2000064876-A1 | TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2000-11-02 | — | — | WO | disclosed |